Clinical Trial Update: A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. [Phase 3]

View source ↗

Summary

Phase 3 trial update for IV casopitant aiming to prevent chemotherapy-induced nausea and vomiting; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• casopitant (casopitant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nausea and Vomiting, Chemotherapy-Induced | Phase 3 | Status: COMPLETED | Results posted: 2018-01-17